The effective registration allows pricing to proceed imminently. Watch for the final pricing announcement and first-day trading performance. The $3.00 assumed price is the reference point; any deviation will signal demand.
Price Chart
Executive Summary
The SEC declared effective Regentis Biomaterials Ltd.'s registration statement (File No. 333-297320) for a firm-commitment IPO of 3,333,334 ordinary shares at an assumed price of $3.00 per share, with a 45-day over-allotment option for up to 500,000 additional shares. The effectiveness clears the way for the company to price and list on NYSE American under ticker RGNT, likely within 1-2 days.
Key Facts
- Effectiveness date: September 22, 2026.
- Registration statement (File No. 333-297320) declared effective under the Securities Act of 1933.
- Firm-commitment offering of 3,333,334 ordinary shares at an assumed price of $3.00 per share.
- Underwriter: ThinkEquity LLC.
- 45-day over-allotment option for up to 500,000 additional shares (15% of the offering).
- Ordinary shares listed on NYSE American under symbol RGNT.
- Company is an emerging growth company and a foreign private issuer.
Financial Impact
Gross proceeds of approximately $10.0 million at the assumed $3.00 price, before underwriting discounts and expenses. Over-allotment could add up to $1.5 million.
Risk Factors
- IPO pricing below the assumed $3.00 would indicate weak demand.
- Post-IPO dilution from the new shares may pressure the stock in the near term.
- As an emerging growth company, reduced disclosure requirements may limit transparency.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-003029 |
| Document: 9999999995-26-003029-index.html | 9999999995-26-003029 |
| Document: 9999999995-26-003029.txt | 9999999995-26-003029 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 6-K | $1.63 | awaiting T+20 | — | $1.26 (−22.46%) |
Sep 23, 2026 4w ago | EFFECT | $2.10 $1.49 | ▼ −29.05% | ▼ −29.74% | $1.26 (−40.00%) |
Jul 20, 2026 14w ago | 6-K | $2.00 $2.04 | ▲ +2.00% | ▼ −2.12% | $1.26 (−37.00%) |
Jul 15, 2026 14w ago | 6-K | $2.43 $1.94 | ▼ −20.16% | ▼ −22.51% | $1.26 (−48.15%) |
Jul 14, 2026 15w ago | EFFECT | $2.54 $1.84 | ▼ −27.56% | ▼ −30.05% | $1.26 (−50.39%) |
Jun 15, 2026 19w ago | 6-K | $9.40 $2.43 | ▲ +74.15% | ▲ +74.15% | $1.26 (+86.60%) |
Jun 9, 2026 19w ago | F-1/A | $2.41 $3.64 | ▲ +51.04% | ▲ +49.59% | $1.26 (−47.72%) |
Jun 8, 2026 20w ago | 6-K | $1.28 $3.58 | ▲ +179.69% | ▲ +178.85% | $1.26 (−1.56%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers